Stock

Kenvue Inc. (KVUE)

NYSE · Consumer Defensive · Household & Personal Products

Profile

Kenvue Inc.

Exchange
NYSE
Ticker
KVUE
Sector
Consumer Defensive
Industry
Household & Personal Products
Country
US

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

Key facts

Kenvue Inc.: key facts

  • Kenvue Inc. (NYSE: KVUE) is a Household & Personal Products company in the Consumer Defensive sector.
  • In fiscal 2025, Kenvue Inc. reported revenue of $15.1B and net income of $1.5B.
  • Revenue was about flat over the last 4 fiscal years.
  • Free cash flow was positive in 5 of the last 5 fiscal years.
  • Net income was positive in 5 of the last 5 fiscal years.
  • Over the last twelve months, revenue was $15.5B and net income was $1.7B.

MonkScore

Kenvue Inc.'s MonkScore

MonkScore

MonkScore range: 50–60

as of October 2026

Sector rank: 174 of 428 in Consumer Defensive

How this score is madeDisclaimer

Pillar ranges

  • Growth30–40
  • Profitability60–70
  • Quality30–40
  • Market Conviction60–70
  • Safety40–50

The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.

Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.

Fundamentals

Figures from the statements

Kenvue Inc.'s annual figures and the last twelve months, in USD. Last report: 27 September 2026.

FigureLast 12 monthsFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$15.5B$15.1B$15.5B$15.4B$15.0B$15.1B
Gross profit$9.1B$8.8B$9.0B$8.6B$8.3B$8.4B
Operating income$3.1B$2.7B$1.8B$2.5B$2.7B$2.9B
Net income$1.7B$1.5B$1.0B$1.7B$2.1B$2.1B
Operating cash flow$2.7B$2.2B$1.8B$3.2B$2.5B$334.0M
Capital expenditure-$190.2M-$475.0M-$434.0M-$469.0M-$375.0M-$295.0M
Free cash flow$2.5B$1.7B$1.3B$2.7B$2.2B$39.0M
Total debt$8.3B$8.5B$8.7B$8.4B$9.0B$129.0M
Cash$1.0B$1.1B$1.1B$1.4B$1.2B$740.0M

Revenue growth a year

1-year
-2.1%
3-year
0.4%
4-year
0.1%

Compound growth between fiscal years.

Peers

Similar companies

See the full analysisKenvue Inc.'s exact MonkScore and pillar scores, in the MonkStreet app

Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click

MonkStreet provides research, not investment advice.

Page built on 31 October 2026.